Mitchel Katz
General Practice · Rocky Hill, CTNPI 1245242601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 203 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Tris Pharma Inc at 29.6% of the total. Reporting peaked in 2019 at $1,196 and has fallen 93.9% since, to $72 in 2025. Among general practice clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $14.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$864
- Neos Therapeutics, LP$565
- Shire North American Group Inc$285
- Arbor Pharmaceuticals, Inc.$250
- Takeda Pharmaceuticals U.S.A., Inc.$231
- Corium, LLC$179
- plus $540 from 6 others
What the payments were for
- Food & beverage$2,915100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 66 | $864 |
| Neos Therapeutics, LP | 54 | $565 |
| Shire North American Group Inc | 17 | $285 |
| Arbor Pharmaceuticals, Inc. | 19 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $231 |
| Corium, LLC | 9 | $179 |
| Supernus Pharmaceuticals, Inc. | 8 | $164 |
| Ironshore Pharmaceuticals Inc. | 3 | $143 |
| Rhodes Pharmaceuticals L.p. | 7 | $115 |
| Adlon Therapeutics L.p. | 5 | $81 |
| Noven Therapeutics, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,915 in reported general payments places this provider in the 95th percentile of 1,190 general practice providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine Sulfate | 11 | $2,320 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 47 | $1,237 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $695 |
| Methylphenidate Hcl | 13 | $413 |
Paid to pharmacies, not to this prescriber.
Other general practice in Rocky Hill
- Vincent RaucciNorth Haven$268K
- Jeffrey HoosStratford$113K
- James CrossHartford$73K
- David FantarellaNorth Haven$33K
- David EdelsonPlainville$29K
- Yousong WangNew Britain$23K
- Michael YoungWindsor$16K
- Julia LathamStratford$13K
- Lawrence ChristianSimsbury$12K
- Alexander QuintnerMilford$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.